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GW researchers lead a five‑year,
multimillion-dollar grant to
explore immunotherapy as a
means to end HIV.

A NOTE FROM ROSS HALL

Dear members of the SMHS community,
BELIEVE is the acronym for the title of the landmark $28
million, five-year National Institutes of Health grant awarded
to GW School of Medicine and Health Sciences (SMHS)
faculty members to work toward a cure for HIV/AIDS. Of
course, it also reflects the confidence that this remarkable
team of researchers and clinicians has to advance our
knowledge of the immune system and our ability to clear HIV
from the body.
Believe is also the theme of this edition of Medicine +
Health. What links these articles is our collective belief in the
SMHS mission and in our outstanding students, residents,
fellows, faculty, alumni, and staff. These stories reflect the
amazing work that takes place at SMHS every day.
Whether you gain inspiration from our diverse student
body and residents in pursuit of their calling to be leaders
in medicine and health care; are excited by the advances in
the basic sciences, translational or clinical research; or are
moved by the impact that our faculty and alumni have on the
communities in which we serve, I hope that you find reasons to
believe in SMHS and make gift to support these efforts.

Philanthropy is an important way for you to express your
belief in SMHS. An unrestricted gift or a gift made to the
dean’s discretionary fund will be used for student scholarships
— my number one priority. However, our terrific faculty also
require support for their efforts to create innovative teaching
models, to perform groundbreaking research, and to provide
cutting-edge clinical care. Giving opportunities are unlimited.
If something in this edition does not match your interests, I
encourage you to pull up the school’s website (smhs.gwu.edu)
and see what else is taking place at SMHS.
Warmest regards,

JEFFREY S. AKMAN, M.D. ’81, RESD ’85
VICE PRESIDENT FOR HEALTH AFFAIRS
WALTER A. BLOEDORN PROFESSOR OF ADMINISTRATIVE MEDICINE
DEAN, SCHOOL OF MEDICINE AND HEALTH SCIENCES

NELSON A. CARBONELL, B.S. ’85
Chair, Board of Trustees
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MAKING THE ROUNDS
Welcoming
Walter
Harris

The Next Chapter
It’s an oft-used metaphor, but in the
case of GW School of Medicine and
Health Sciences students, it’s apt:
Graduation is the end of a chapter in a
long story of health care. For medicine
and health sciences students, it’s a
narrative of intense study, little sleep,
and immense personal growth.
As the graduates of 2016 learned,
the next act of their professional lives
hinges on their ability to build on
their skills and knowledge, and their
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compassion and collaboration, as they
move to residencies, internships, and
clinical care.
“[Your story] is only partially
written, but it’s off to a great start,”
M.D. program graduation keynote
speaker Jonathan B. Perlin, M.D., Ph.D.,
M.S.H.A., MACP, FACMI, president
of clinical services and chief medical
officer of the Hospital Corporation of
America. “Bravo!”

The GW School
of Medicine and
Health Sciences
(SMHS) has
tapped Walter
Harris, M.B.A., PMP, as the senior
associate dean for administration and
operations, a new position within the
Office of the Vice President for Health
Affairs and Dean of SMHS. Harris
comes from the U.S. Food and Drug
Administration, where he served as
the deputy commissioner for opera‑
tions and chief operating officer. At
SMHS, he will spearhead business
and management efforts designed
to balance strategic and operational
initiatives. He will also be responsible
for SMHS operations and adminis‑
tration, including communications,
strategic planning, financial planning
and accounting, information tech‑
nology, human resources, facilities, and
safety and security.
Harris has won multiple awards
and honors, including the Executive
Leadership in Government Award from
the Association for Federal Information
Resource Management, the Top
Blacks in Healthcare Award from
BlackDoctors.org, and the Centers for
Disease Control Directors Award. He
also served as a sergeant in the United
States Air Force and was selected as
the Pentagon liaison to Secretary of
Defense Caspar Weinberger.
“Coming to the GW School of
Medicine and Health Sciences is a
wonderful next step in my career,”
Harris said. “I am pleased to be joining
a dynamic team.”

DONNING THE
WHITE COAT

The white coat: a piece of fabric whose
meaning belies its simplicity. It repre‑
sents a responsibility to patients; a
commitment to healing; and a passion
for the craft of medicine. For new
students, slipping into the white coat
also signifies entry into the profession,
a milestone treated with ceremony.

First-year M.D. program students
formally donned their white coats in early
August; physician assistants, as well as
incoming residents, received their white
coats in late June. Physical therapy (PT)
students, with help from second- and
third-year PT students, put on theirs in
the fall.

“This has been the last eight years
of my life, trying to get to this point,
and it feels like a dream that I really
don’t want to wake up from,” said firstyear M.D. student Paola Mancera at her
ceremony. “I’m on the verge of crying
and trying not to cry this soon, but it is
the most surreal experience.”

Meron Rezene, a senior at E.L. Haynes Public Charter
School in Washington, D.C., waits to deliver a baby in the
Clinical Learning And Simulation Skills Center during the
annual four-week DC Health and Academic Preparation
Program (DC HAPP). The program, designed to immerse
rising high school seniors in the field of medicine,
includes lectures, poster presentations, and hands-on
activities, such as lessons in suturing and CPR training.
The DC HAPP cohort also receives white coats, a symbol
of entry into health care, in a special ceremony.
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Practical Medicine in the Historical Setting
Students in the GW School of Medicine
and Health Sciences (SMHS) M.D.
program could easily be spotted
among the deluge of people eager
to attend the opening of the National
Museum of African American History
and Culture, but they weren’t there as
spectators. Instead, the students and
SMHS faculty were on hand to provide
an important service during the
historic event.
The GW Medical Faculty
Associates (GW MFA) Department of
Emergency Medicine was called upon
to provide medical support at the
event, and at least a half dozen medical
students volunteered their time and
services throughout the weekend, said
Yolanda Haywood, M.D., RESD ’87,
B.A. ’81, associate dean for diversity,
inclusion, and student affairs at SMHS.
During the opening, students
took blood pressure, attended to
minor wounds, and assisted the
medical team triaging the injured or
ill attendees. The opportunity put
students at the center of the action
providing medical care at a large
public event, Haywood said.
Jené Carter, a second-year
medical student who volunteered at

the event, said she participated in
order to put into practice the skills she
had learned in class while also being
part of “a huge, historic moment.”
Washington, D.C. is a vibrant city
full of events and festivals, and for
GW medical students, volunteering
at activities that only this city holds “is
really valuable,” Carter said.
She added that she felt a bit
nervous about having the right skills
required for whatever might come
up, but found comfort in the sense of
teamwork among the students, nurses,
and providers. “Everyone was really
collaborative,” she said.
Occasions such as the museum
opening, Haywood added, show
students how much organization and
skill is required to provide medical
care at a large event. And with one so
momentous, “just to be part of that was
a great opportunity, no matter what
your role was,” she said.
GW students and staff will also
play a role at an event that’s completely
unique to D.C.: the presidential
inauguration.
The GW MFA Medical Reserve
Corps (MRC), a medical response
and disaster team, is gearing up for

the event, most recently holding an
active shooter medical response drill
in partnership with the U.S. Park Police,
as well as D.C. police, fire, and EMS
departments, among others, said Drew
Maurano, PA-C, director of event and
operational medicine and GW MRC,
and associate clinical professor of
emergency medicine at SMHS.
Faculty and staff took part in the
drill, with about 15 medical and physi‑
cian assistant (PA) students acting
as responders, and more than 100
medical, nursing, and PA students
playing the role of victims. Six SMHS
faculty members were present to help
lead the drill, Maurano said, praising
the level of “involvement from the
medical students and medical faculty.”
Carter expressed interest in
the drill, which she said is necessary
because horrible things happen — and
as an aspiring physician, it’s important
to be prepared for anything.
As for the part medical students
and faculty will play at the inaugura‑
tion and events surrounding it, that
will come down to the needs of the
inauguration committee put in place
by the presidential transition team,
Maurano said.

Service Learning: As part of the annual SMHS
Community Service Day, first- and second-year M.D.
program students, as well as doctor of physical therapy
students, split into shifts to volunteer with a variety of
organizations: Nourishment Now, Operation Smile, Best
Buddies, the Children’s Inn at the National Institutes of
Health, and the Audubon Naturalist Society.
“I think [volunteering] is something not a lot of people
take the time to step out of their comfort zone to do, so
it was really nice to take that extra step and bring this to
people’s doorstep so they can see the impact that they’re
making in people’s lives,” said co-chair Robyn Frankel, a
second-year medical student. “It’s pretty meaningful.”

4
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Going Global on
Regulatory Science

Becoming “One GW”
From undertaking innovative research
and treatment to educating health
care professionals, the GW School of
Medicine and Health Sciences (SMHS),
the GW Hospital, and the GW Medical
Faculty Associates have established
a foundation of collaboration and
achievement. Now, however, the three
— under the umbrella “One GW” — are
strengthening their bond with a new
alignment and structure.
One GW has three goals: offering
patients the most comprehensive and
highest quality of care; training the
next generation of medical profes‑
sionals with technically advanced
clinical techniques and modalities; and
advancing biomedical, translational,
and health services delivery research
to improve patient outcomes.
This new approach will allow each
medical entity to better combine its
efforts and resources on key service
lines and research opportunities.
Additionally, One GW will empower

physicians to participate in a shared
governance model, providing them
with a more active role in decisionmaking and planning for success.
To celebrate the launch of One
GW, the three entities welcomed
nearly 4,000 employees, staff, resi‑
dents, and students for a catered
meal, complete with ginger-glazed
pineapple and jerk pork, corn on the
cob, and ice cream, held in the Eye
Street Mall in mid-September.

Industry experts, working profes‑
sionals, and students from both the
Regulatory Affairs Program at the
GW School of Medicine and Health
Sciences (SMHS) and abroad gathered
in Foggy Bottom for the first interna‑
tional annual summer institute, “Issues
& Trends in Regulatory Science.”
The event, organized through a
collaboration between SMHS and the
European Center of Pharmaceutical
Medicine at the University of Basel,
Switzerland, featured prominent
industry leaders and discussions on
topics like how health care products
are cleared or approved for marketing;
the future of drug and medical device
innovations; how the reimbursement
process works; pending legislation that
might change the way health care is
delivered; and the One Health Initiative
that aims to improve health care for all.
“It was an invaluable experience,”
said Emily Swanson-Parker, a class of
2017 student in the SMHS Regulatory
Affairs program. “[This] wasn’t your
run-of-the-mill professional confer‑
ence, and I think that’s what made this
conference stand out.”
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MAKING THE ROUNDS
Yarne Glascoe poses in the gym where
she works out, strengthening her body
after surgery. A few months before,
Glascoe received a kidney donation
at the GW Transplant Institute at GW
Hospital. Glascoe was one of several
patients who received a new kidney
this year. As of December 2016, the
Transplant Institute, with surgeons J.
Keith Melancon, M.D., chief of the GW
Transplant Institute and professor of
surgery at the GW School of Medicine
and Health Sciences (SMHS); Thomas
Jarrett, M.D., chair and professor of
urology at SMHS; and Muralidharan
Jagadeesan, M.B.B.S., associate
professor of medicine at SMHS,

New Head for Health
Sciences
Reamer L. Bushardt, Pharm.D., PA-C,
DFAAPA, tenured professor and chair of
the Department of Physician Assistant
(PA) Studies at Wake Forest Baptist
Medical Center’s School of Medicine,
was named senior associate dean for
health sciences at the GW School of
Medicine and Health Sciences (SMHS).
Bushardt will lead all health sciences
departments at SMHS, including the
departments of PA studies, physical
therapy and health care sciences,
clinical research and leadership, and
integrated health sciences.
In addition to leading the
Department of PA Studies at Wake
Forest, Bushardt was a professor in
the Department of Internal Medicine,
professor and program leader in Wake
Forest’s Clinical Translational Science
Institute, and professor in the W.G.
Hefner VA Medical Center.
As an active researcher engaged
in health workforce and educational
research projects, Bushardt has
published extensively on the education
and training of health care professional
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students and leaders, interprofessional
education, and collaborative practice
models. He also serves as editor-inchief for the Journal of the American
Academy of Physician Assistants.
Bushardt will assume the role
of senior associate dean for health
sciences on Jan. 1, 2017.
Stepping down from this position
is Joseph Bocchino, Ed.D. ’03, M.B.A.,
who served as senior associate dean for
health sciences for the last four years.

Reamer L. Bushardt, Pharm.D., PA-C,
DFAAPA

has performed more than 80
kidney transplants.
Working in concert with the
GW Transplant Institute is the GW
Ron and Joy Paul Kidney Center,
which recently kicked off a major
kidney health education campaign.
Bus, television, radio, and digital
media advertisements encour‑
aging Washington, D.C. residents
to check their kidney health will
appear throughout the year. The
campaign will also include informa‑
tion sessions and free screenings,
particularly in Wards 7 and 8, where
kidney disease is widespread.

Passing with Flying Colors
Graduates from the GW School of
Medicine and Health Sciences (SMHS)
Physical Therapy (PT) Program have, for
the seventh consecutive year, achieved
a 100 percent first-time pass rate on the
National Physical Therapy Examination
(NPTE). The NPTE is a rigorous, compre‑
hensive exam that all PT graduates must
pass in order to be eligible for licensure.
“This level of success is exemplary
and a testimony to our strong graduates,
our excellent faculty, and a curriculum
reflective of contemporary practice
standards,” said Joyce Maring, Ed.D.,
DPT, program director for the Doctor of
Physical Therapy program and chair of
the Department of Physical Therapy and
Health Care Sciences at SMHS.

CELEBRATING
A MILESTONE

T

BY CAROLINE TRENT-GURBUZ

he George Washington
University Institute for
Spirituality and Health
(GWish), established in
2001 to promote whole-person care by
integrating spirituality into health care
and education, marked a milestone this
year: its 15th anniversary. To commemorate the occasion, GWish welcomed
members of the community, including
political and academic luminaries, to a
special dinner.
“I think 15 years is amazing,”
said Kathryn M. Braeman, chair of
the GWish Advisory Board, as she

acknowledged the work of GWish
founder and director Christina
Puchalski, M.D. ’94, RESD ’97, FACP,
FAAHPM. “[Dr. Puchalski] has been
a pioneer in creating awareness of the
importance of spirituality in health. She
is a visionary on a national and global
scale.”
Thanks to Puchalski and GWish’s
efforts, spirituality is now recognized
as a vital contributor to health — a
prominent theme throughout the
evening. In addition to Braeman’s
introduction, U.S. Representative
Fred Upton from Michigan’s 6th
District and keynote speaker Robert
Boisture, president and CEO of the
Fetzer Institute, acknowledged the
organization’s work.
“We’re here to celebrate a wonderful
cause,” Boisture said. Those in
attendance, he explained, though
they may come from a variety of
backgrounds, cultures, and religions,
share a passion. “The common
denominator, I think,” he said, “is
compassion, is opening our hearts to
the pain and suffering of the world
with hope and a commitment to try
to do something about it.”
With that compassion in mind,
GWish presented its inaugural
Excellence in Interprofessional

Betty Ferrell, Ph.D., M.A., FAAN,
FPCN, CHPN

Christina Puchalski, M.D. ’94, RESD ’97,
FACP, FAAHPM

Spiritual Care Award to Betty Ferrell,
Ph.D., M.A., FAAN, FPCN, CHPN,
director and professor in the Division
of Nursing Research and Education,
Department of Population Sciences, at
City of Hope Hospital.
“I don’t at all take this lightly, this
recognition, because I know I’m in a room
of many kindred spirits and people who
are dedicated to ideas about love and
spirituality,” Ferrell said. “I think for many
of us in the room, there is the work we are
asked to do every day, but deep within us
there’s the work that we were born to do.”
That’s the work, she said, that GWish
does: attending to people’s spiritual needs
to help them heal and find hope.
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imberly Russo, M.B.A., M.S., pauses in the description of her hometown, White Hall, Illinois,
population 1,100, to mock-gasp. “Everyone was like,
‘We have a stoplight!’” The flashing red light, which
was installed when Russo was in high school, was “a very, very
big deal,” she explains, laughing. But Russo wasn’t meant for
life in a one-stoplight town, though rural health care has always
remained near and dear to her heart. She did stay in her home
state, at first, attending Illinois State University, then graduate
school at Rush University and a fellowship in speech-language
pathology at a Northwestern University affiliate, until opportunities steered her in another direction. Here, the new CEO
and managing director of GW Hospital discusses the path that
took her from clinical care to hospital management, what that
means — or doesn’t mean — for women breaking through glass
ceilings, and her vision for the hospital.
Q: Tell me about your transition from academia and clinical
work to hospital administration.

KIMBERLY
RUSSO:
On Learning, Goals,
and Her New Role as
CEO of GW Hospital
BY CAROLINE TRENT-GURBUZ
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A: I did my fellowship at a Northwestern affiliate for
speech-language pathology/audiology and then my husband
and I moved to the D.C. area for his career; I ultimately
landed here at GW Hospital as a clinician and a bedside
speech-language pathologist. I proceeded through the
management path at GW, and I was actually in my Ph.D.
program at the University of Maryland when I got some
opportunities within GW; I really needed to take a leave
of absence from my Ph.D. studies in order to pursue them.
I made a critical decision and took a risk, which I think is
sometimes part of leadership — you have to take those risks.
I absolutely loved [going down the management path] and
felt that I was making a larger impact and a difference in a
very meaningful way.
I proceeded to administration and earned my M.B.A.
during my first administrator role, feeling that I needed to go
back and really continue to educate myself on the business and
leadership philosophies. [I was then] chief operating officer
for seven years and ultimately became the CEO following that
stint in administration.
Q: What were you pursuing as your Ph.D.?
A: It was in speech-language pathology and audiology with a
focus on neuropsychology and aphasiology. So, very interesting
[laughs]. It really was on working memory, post-stroke, those
types of things.
Q: What was it like switching from that to an M.B.A.?
A: You know, it’s a different animal, but I promised my
husband it would be my last degree. I am very much an
academician at heart and would be in school all the time if I
could. I love higher education and learning, so for me, it was
something I felt I needed for my own career path and also to

develop my knowledge and my critical thinking skills to really
be successful in the administrative role.
Q: Do you miss clinical work with speech-language pathology?
A: I miss that direct patient contact and the clinical aspect
of it. However, in this role, I feel that I’m able to fulfill that
void by being out and about and rounding with the staff. I feel
that my clinical background helps me not to be hesitant or
nervous; I’m able to use my speech degree and communication
to connect with patients in a more meaningful manner than is
typical for administrators.

The staff are, to me, our most
valuable asset, and we want to
continue to develop and recognize
and engage them to help us provide
better service to our community.
Q: Does your clinical background make you, as an administrator,
feel better able to handle whatever situations come up?
A: I think having the clinical background, coupled with the
business education and the experience that I’ve been blessed to
have throughout my career, has really shaped and prepared me
for the role. I’m able to bring that clinical perspective and keep
the patient in the forefront of all the decisions that we make. I
pride myself on doing that. I do think it makes a little bit of a
difference; I can understand some of the clinical “asks” as well
as the business “asks” that come into this role, and it also helps
me more easily navigate through the priorities.
Q: In terms of the hospital itself, what goals do you have?
A: GW Hospital wants to continue — and my vision is to
continue — the real focus on our academic-quaternary-tertiary
center and serving the community’s needs during critical
medicine and complex care. Being a quaternary center means
that we are able to offer the D.C. region a level of specialized
care that is not widely available elsewhere, including advanced
technology and procedures.
As we continue to expand and increase our level of care, we
remain committed to our alignment with the School of Medicine
and Health Sciences as well as the GW Medical Faculty
Associates. Together, we make up the GW clinical enterprise,
and we are able to offer comprehensive, research-based care.
One area that we will focus on together in the coming
years is our cancer program, which is a strategic initiative and
growth imperative for the clinical enterprise. In addition to
that, in order to really fulfill that academic-quaternary-tertiary
vision, we have to continue to offer complex medical care, which

involves highly complex surgery, trauma, and transplants. That
has to be [paired] with innovative research and bringing new
technologies and new procedures to the region — that’s really
where the clinical enterprise is aligned, in pushing that vision.
Q: Why is the continued alignment with the GW School of
Medicine and Health Sciences and the GW Medical Faculty
Associates important to your vision?
A: As an academic medical center, we are committed to training
the next generation of health care providers. The School of
Medicine and Health Sciences is part of the fabric of who we are
as a hospital. That strategic vision of alignment — being able to
expand our footprint as an enterprise and provide the highestquality service to meet the community’s needs by offering
greater accessibility — is key for that clinical enterprise.
Q: What valuable asset does GW Hospital bring to the table
for that alignment?
A: We talk about the vision of the hospital, and we always have
our business imperatives at the forefront of our mind — but I’ve
been very focused on staff as well. I am committed to making
GW Hospital not only a provider of choice for patients but also
an employer of choice.
I think the staff are really the heart of this organization,
and they are the reason we’ve been able to provide the care
and the health care access to our patients. In an effort to
engage staff, I’ve recently started an employee advisory
council. They want to know that their voice is being heard,
and it is my job as a leader to ensure that I am welcoming their
ideas and addressing their concerns. The staff are, to me, our
most valuable asset, and we want to continue to develop and
recognize and engage them to help us provide better service to
our community.
Q: There aren’t too many female hospital CEOs. How do you
feel about rising to this level? Do you feel like you’ve broken a
glass ceiling?
A: I think it’s important to constantly keep in the forefront of
the mind that you’re hired for your knowledge and skills and
leadership to fulfill an objective. I have a pretty big objective to
fulfill here as CEO. I don’t think it’s really about being male or
female; it’s about the skills that you bring to the table to fulfill
those objectives at the time. It is absolutely a rare situation —
between 1.6 and 2.6 percent of health care leaders are female
CEOs, and there are about 5,700 hospitals in the nation — and
I believe there are continued gender diversity issues within the
health care industry.
It is, absolutely, a humbling experience. I’m very honored
to be the CEO of GW Hospital and to be part of the clinical
enterprise that I think is very strong, given that the medical
school is one of the oldest in the nation and we have the largest
faculty plan in the region. That, to me, is very humbling.
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Going
to
Great
Pains

T

BY CAROLINE TRENT-GURBUZ

he patient was addicted to heroin,
recalls Katharine Hindle, M.D.,
assistant professor of anesthesiology
and critical care medicine at the
GW School of Medicine and Health
Sciences (SMHS). GW Hospital staff
screen all incoming emergency room
patients for opioid and drug use — it’s
standard operating procedure — and Hindle, in talking with
the patient, found that he was actively using the drug. Digging
deeper, she learned that he was self-medicating for hip pain.
“He was at the point where he was very candid about the
fact that he didn’t want to continue,” she says. “His goal was to
go home on no additional opioids.”
Managing his pain as part of that goal is precisely what
Hindle and the Acute Pain Management Service, led by Paul
Dangerfield, M.D. ’95, RESD ’02, B.S. ’89, assistant professor of
anesthesiology and critical care medicine at SMHS, can offer. It
is, Dangerfield says, the team’s small way of taking a bite out of
opioid addiction.
Statistically speaking, opioid addiction has cracked the
level of epidemic. Since 1999, sales of prescription painkillers —
oxycodone, hydrocodone, morphine, fentanyl, codeine — have
quadrupled, according to the Centers for Disease Control and
Prevention. Four in five heroin users first become addicted
by misusing painkillers, the American Society of Addiction
Medicine reports, and drug overdose is the leading cause of
accidental death in the country.
Using opioids, Dangerfield explains, is like treating pain
with a hammer, rather than a needle: Opioids target pain “in
a blunt way, in that they not only target the pain, but they
target everything else,” he says, which can lead to undesirable
side effects. Dangerfield also warns that bluntly targeting the
pain doesn’t completely eliminate it, leading to an escalation
in dosage, which puts the patient at higher risk for addiction
and other negative side effects (nausea, vomiting, constipation,
dysphoria). At GW Hospital, however, the Acute Pain
Management Service is combining medications and techniques
to more precisely target pain and reduce the need for opioids
almost completely.
“We use a number of different medications that work in
different ways on the pain, what we call regional anesthesia,”
Dangerfield explains. “If people need it, they get opioids — but
instead of that being the foundation of what we’re doing, our
goal is, through this multimodal pain regime, [to give them
fewer] opioids. If people aren’t exposed to them in the first
place, they’re less likely to become addicted to them, and their
pain is treated effectively.”

GWMEDICINEHEALTH.COM

11

Multimodal
Pain
Management
• IV therapy (morphine)
• Anti-inflammatory
• Bupivacaine (epidural)
• Muscle relaxant
• Pills (opioids)

After being diagnosed with breast cancer, Robyne Doyle
opted for the multimodal approach for her double mastectomy
and breast reconstruction because, she says, “I know pain.”
Doyle was a nurse in the GW Hospital ICU for almost 30
years. “I think some people who are not in the medical field
don’t have a grasp of how painful that surgery is,” she says. “I
was fully aware. It’s not a walk in the park.”
Dangerfield treated Doyle with the paravertebral nerve
block, a kind of regional anesthetic. Doyle had two small,
flexible catheters inserted in her back, one on each side, that
continually released medication over the course of a few days,
a time period determined by the team. The catheters were
connected to a softball-sized, portable bag of medication kept
in pouches, which Doyle strapped around her waist.
Despite having opioids or painkillers on hand in case her
postoperative pain became overwhelming, Doyle found that
it was nearly nonexistent. “When I got home, I still wasn’t in
pain. I mean, I’m toddling around — most people are down for
the count for five to seven days, writhing in pain, can’t get out of
bed, can’t move around; that’s just the nature of the mastectomy.
Here, I’m hanging out with my kids, walking my kids to the bus
stop, doing dishes the minute I get home.”
As Dangerfield explains, Doyle’s experience isn’t unusual:
“Here’s someone who goes under, on a lot of different levels,
a very significant surgery. She feels well enough to do [daily
activities], as opposed to the patients who don’t get this
[treatment] who are really laid up for a while and are not only
miserable from the pain, but miserable from the side effects of
the medication.”
Looking back, Doyle believes the multimodal approach
was a kind of gift, a blessing even, that she learned was
almost unique to her. “A few people — someone’s secretary or

12

MEDICINE + HEALTH | FALL 2016

someone’s sister-in-law — would get diagnosed, and I would
tell them all about this procedure,” Doyle recalls. “Of course,
they had never heard of it, and I almost felt bad talking about it
because I felt like it was a special gift I had been given. I guess
[although] GW does them, not every hospital does.”
GW Hospital, the Acute Pain team explains, is one of
the few institutions using this multimodal approach — but
not because it’s so “super-secret and super-special that we’re
the only ones who can figure it out,” Dangerfield says. The
issue, he says, is a lack of education on pain treatment options:
combinations of the regional anesthetics, ketamine infusions,
IV therapy, anti-inflammatories, and muscle relaxants.
To combat that lack of knowledge, SMHS has made pain
management a component of the medical curriculum. Students
rotate with the team for two to four weeks, and Marian
Sherman, M.D. ’99, assistant professor of anesthesiology
and critical care medicine at SMHS, lectures on the topic.
Likewise, the team, says member Jessica Mersinger, an R.N. at
GW Hospital, is “approachable and willing to educate, so we
have residents who rotate through the service, who work with
us managing the medications, and they take that back to their
colleagues, [such as] the orthopedic team.”
“The Pain Cave,” as the Acute Pain team office is known,
also has a reputation for luring in GW Hospital health care
staff through treats — especially Oreos — in order to discuss
pain management options. “Even if it’s not an official consult,
people will know who we are and stop us and say, ‘What do
you think about this? Could I try this, could I try that?’”
Dangerfield says. “It’s being that Pied Piper to get as many
people as possible to do what we do.”
The benefits of the Acute Pain Management Service
extend far beyond just mitigating suffering for those undergoing
surgery; surgeons who use the Acute Pain team find that their
patients’ satisfaction increases, as does their practice, and
patients feel cared for, thanks to the service’s 24/7 availability
by phone and counseling options. It’s what makes the program
special, Dangerfield adds: GW Hospital not only provides for
the service, but also provides for support staff — four nurses
and two nurse practitioners — to make sure patients receive
comprehensive care at all times. “It’s truly what sets us apart,” he
says. The team plans to add telemedicine soon, as well.
“If all hospitals had an acute pain service that treated
those patients [addicted to opioids] effectively, there would be a
lot fewer patients going out on the street with Price Club-sized
containers of opioids or going out and getting street drugs to
treat their pain because the doctors didn’t treat it correctly,”
Dangerfield says. “One mistake did not get us here, and one
correction is not going to get us out. But if every hospital
adopted what we did, it would be a big step in getting ahead of
the initial problem.”

SMHS Receives Full,
Eight-Year Accreditation

T

he GW School of Medicine and Health Sciences
(SMHS) received full accreditation for an eightyear term from the Liaison Committee on Medical
Education (LCME), June 22. The accreditation
process, which determines whether an M.D. program meets
established LCME standards, involves an intensive three-day
site visit. Programs must demonstrate that graduates exhibit
professional competencies appropriate for the next stage of
training, and those competencies need to serve as a foundation for lifelong learning and proficient medical care.
“This is an outstanding outcome — and I am grateful to
the incredible team of students, faculty, staff, and deans who
worked extremely hard to achieve this result,” says Jeffrey S.

Akman, M.D. ’81, RESD ’85, vice president for health affairs,
Walter A. Bloedorn Professor of Administrative Medicine, and
dean of SMHS.
The formal LCME report indicated that the SMHS M.D.
program was in compliance with all accreditation standards,
with two classified as “compliance in need of monitoring.”
“This was a remarkable accreditation survey that gives
us much to be proud of,” says Richard J. Simons, M.D.,
senior associate dean for M.D. programs, who led the
LCME accreditation effort for SMHS. “As we move forward,
we will continue to strive for excellence on all levels of
medical education.”
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Translating
OPPORTUNITY
GW’s School of Medicine and Health Sciences, the

Milken Institute School of Public Health at GW, and
Children’s National Health System Earn Renewal
of their Five-Year Clinical and Translational
Science Award

W

hat we learn about childhood diseases today
can potentially affect present efforts in fighting
ailments plaguing adults — and the partnership
between the George Washington University
(GW) School of Medicine and Health Sciences (SMHS),
the Milken Institute School of Public Health at GW, and
Children’s National Health System (Children’s National) is
allowing for significant strides, thanks to the Clinical and
Translational Science Award (CTSA).
The $23 million grant represents not just a fiveyear extension to the original award the partnering
institutions received in 2010, but it also is an expansion of
the organizations’ original goals: enhancing clinical and
translational research; overcoming research barriers and
promoting collaborative research; providing research training;
and focusing on health disparities and childhood forerunners
to adult diseases.
The partnership, known as the Clinical and Translational
Science Institute at Children’s National (CTSI-CN), continues
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BY ERIC BUTTERMAN

to be the only CTSA program out of the 64 in the nation with
an emphasis on children, according to Robert Miller, Ph.D.,
senior associate dean for research, Vivian Gill Distinguished
Research Professor, and professor of anatomy and regenerative
biology at SMHS.
Lisa Guay-Woodford, M.D., director of the CTSI-CN,
Richard L. Hudson Professor of Pediatrics at Children’s
National, and associate vice president for clinical and
translational research at GW, says the second version of the
CTSA will answer a few central questions: What are the
challenges for child health in translational science? How can
we help investigators who want to take them on? How can we
help these investigators in developing studies that can be done
across the consortia? And, from an extended perspective, how
can we interact with other CTSA programs to develop best
practices from which all can benefit?
“I think the CTSA program nationally is all about being
sure that people are really prepared to do effective clinical and
translational research, to do it an efficient way where we don’t

waste people’s time or resources, and
where we really kind of get to the nut of
the issue as quickly as possible,” GuayWoodford says.
To maximize that efficiency,
CTSI-CN will use the renewal grant
to focus on informatics, workforce
development, collaboration, and
community engagement.

BY THE NUMBERS

WORKFORCE DEVELOPMENT: Develop a new generation
of diverse, high-quality, child health-focused clinical
and translational research (CTR) investigators through
educational, training, and mentoring programs.

COLLABORATION + ENGAGEMENT: Create unique
approaches and technologies to catalyze CTR, particularly in
child health, through novel cross-disciplinary collaborations
that engage multiple stakeholder communities.

METHODS + PROCESSES: Spark the development,
evaluation, and dissemination of methods to enhance CTR,
with an emphasis on the child-health CTR spectrum from
conception to adulthood.

INTEGRATION: Foster multidisciplinary teams capable
of conducting child-health CTR across the translational
spectrum to address health disparities, fetal/maternal
medicine, and rare genetic diseases.

INFORMATICS: Advance child-health CTR through a
comprehensive, integrated information ecosystem, with
user-friendly training in informatics methods and tools.

Informatics, or the science of
information, is right out in front in
terms of the CTSA program’s focus.
Informatics holds the power to advance
care, but challenges remain in the
collection and sharing of patient data,
says Lawrence Deyton, M.D. ’85,
M.S.P.H., senior associate dean for
clinical public health and professor of
medicine at SMHS, and co-director of
the regulatory knowledge and science
core for CTSI-CN.
“There are many disciplines
crossing and in different kinds of
research,” Deyton says. “It goes from
basic lab research to genetics research
to even public health research. But for
all aspects, there are requirements in
terms of ethics and transparency, and it’s
important to do research in a way where
patients and the community know what’s
going on and that participants consent
with full knowledge.”
A prime challenge is putting
together an information system that
allows the medical community access to
informatics in a way that is effective and
well-organized. “There’s a lot of data and
you need to query those data efficiently
and manipulate it efficiently so the
information is in a safe and cyber secure
environment — that’s the trick,” says
Keith A. Crandall, Ph.D., director of
GW’s Computational Biology Institute
in the Milken Institute School of Public
Health. “We have an exceptional team
working on this. From bioinformatics
platforms to tool developers to data
analyzers to cybersecurity experts and

internet trafficking experts, we collaborated with the Division
of Information Technology on this proposal because they know
the ins and outs of data security and how to move data around
from place to place efficiently and securely.”

FIELDING YOUR TEAM

Translational Workforce Development is another vital
area, says Guay-Woodford. She compares it to choosing
occupational therapists or psychotherapists to put on your
research team. They can be a great asset, but it’s like asking
a soccer player to make a game-day switch to baseball — the
players are great athletes, but you need to show them how to
play the game and give them the tools to succeed.
Just as there are different positions with unique roles
and responsibilities on the athletic field, the CTSI-CN is
customizing on-demand training to different groups to match
their needs. One example is training for clinical research
associates; they need to become savvy about regulatory, billing,
and data management issues.
From Guay-Woodford’s perspective, if everybody on the
team understands the game that is being played, what their role
is, and what they need to do to work well together, you’ll end up
with a winning team.
Amanda Kasper, M.P.H. ’09, director of operations for
CTSI-CN, also likes how the award extends to a wide breadth
of talent. “Educating and preparing the faculty reaches wide, to
the nursing staff, clinical research staff, and beyond,” she says.
“We want it to be across the workforce, using existing and new
educational activities. A highlight is the number of internships
being offered to scholars … to spend time in prestigious
organizations and get hands-on experience is very valuable.”

PLAYING TO YOUR STRENGTHS

The award also allows for the individual CTSA program to
choose a pair of optional modules on which to focus. Orphan
product acceleration, or the development of treatment options
for rare diseases, is something about which many of the
researchers involved with CTSI-CN are excited.
“We have a really strong history of drug development,
particularly in the muscular dystrophy space and also pediatric
device development,” Guay-Woodford says. The idea of this
module was to provide an entry for an interested investigator
to understand the steps needed to go down a path of drug
development or device development, among them dealing with
regulatory issues and business planning.
The other module, Child Health Research Acceleration
through Multisite Planning, or CHAMP, focuses on how
investigators from multiple institutions can work together on
research and act on issues such as recruitment, ethics, and data
collection. A team-building immersion boot camp to be held

annually at the University of California Irvine, focuses on the
CHAMP themes, such as building a team through intrastream
communication and how a team operates together.
Community involvement also remains an important
feature of the CTSI-CN now that it’s shifted to the second
version. A standout, Kasper says, is Science Café, a quarterly
event held at Washington, D.C. staple Busboys and Poets,
where community members participate in a discussion on
medical topics. “It’s a chance to share research and help the
community at large learn about a disease,” she says. “We’ve
seen many people come to the event connected to the disease
topic being featured in some way, [and] subjects have included
sickle cell and asthma. The community engagement team
works hard with the community to figure out their defined
needs of what they want to learn about. Our advisory group of
parents and community members are vital in giving us insight
on possible programs for the community.”

Just as there are different
positions with unique roles and
responsibilities on the athletic
field, the CTSI-CN is customizing
on-demand training to different
groups to match their needs.

LOOKING DOWNSTREAM

In a presentation to the SMHS Dean’s Council, GuayWoodford says one strength of the CTSA is the opportunity
to cross-train researchers and clinicians. “We will help
investigators build their databases, recruit their patients,
design their studies, prepare their IRB proposal, run their
studies, and help them with community outreach,” she said
during the talk.
It’s early, but Kasper sees the second round of this
partnership flourishing since the award was given in July, and
she is optimistic about what’s coming next. “Downstream,
you see the effects of the clinical trials that are going through,
and you see the infrastructure moving innovations that much
more,” she says. “This is a great fusion of two institutions
combining strengths.”
With empowering assistance to the medical community,
Miller believes this second five-year cycle has a chance to lead
to an incredible period of prosperity.
“So much of this builds through the community working
together, but also among the CTSAs,” he says. “It makes us
strong to have such a large number of people at the ready to
share insights.”
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CANCER
ON THE
MOVE
GW Cancer Center Moves into
New Collaborative Space Atop the
Science and Engineering Building

T

BY KATHERINE DVORAK

he days of basic scientists laboring in virtual isolation in their labs in search of the next discovery
are well in the past. In today’s research world,
collaboration is key. That’s never been more evident
than in the sparkling new facilities on the eighth floor of
George Washington University’s (GW) newly built Science and
Engineering Hall (SEH). The SEH reflects the importance of
having a space dedicated to collaboration across disciplines.
The facility, which spans 500,000 square feet, is the
largest academic building dedicated to the fields of science and
engineering in Washington, D.C., and the very top floor is now
home to a growing number of cancer research labs run by GW’s
School of Medicine and Health Sciences (SMHS).
Having the space allows SMHS to broaden its research
efforts, especially when it comes to cancer and translational
science, says Edward Seto, Ph.D., associate center director for
basic sciences at the GW Cancer Center (GWCC) and professor
of biochemistry and molecular medicine at SMHS.
Two areas of emphasis in the labs are cancer epigenetics
and immunology and immunotherapy, says Seto, who provides
leadership for the development, implementation, and evaluation
of basic science–related programs and initiatives. He says scientists will also dedicate research to microbial oncology, work that
will be done with the help of the Department of Microbiology,
Immunology, and Tropical Medicine.
In addition, the space will better foster collaboration
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between students and researchers in both SMHS and the School
of Engineering and Applied Science, Seto says.
“A lot of non-scientists think research is [performed by]
someone who’s doing experiments alone in the basement or
garage,” he says. “But that’s not how science is done. Scientists
have to work together, where they can bounce ideas off each
other and work in groups to do things beyond each [person’s]
expertise.”
Every inch of the new floor, Seto goes on to say, “has been
designed to promote collaboration and the exchange of ideas.
With everyone working together, good ideas are bound to come
out of it.”
Currently, seven SMHS labs occupy the eighth floor. When
the floor is completely filled, Seto expects to have between 12
and 15 labs in the space.
The floor also features 19 offices, 60 workstations, and
common and meeting areas. It is outfitted with state-of-the-art
equipment that will help researchers carry out their molecular
biology, biochemistry, and cell biology work. In addition, the
floor will house a new facility in which to perform patientderived xenograft model studies, a preclinical platform that will
help predict the effectiveness of novel chemotherapeutics for
cancer patients.
Seto says the building and the eighth floor show GW’s
commitment to advancing both science and engineering, a strategic goal of the institution.

AT THE CORE

Within the 500,000 square feet of the new Science
and Engineering Hall (SEH), researchers and students
from the George Washington University (GW) School
of Medicine and Health Sciences (SMHS) are hard
at work not only on the eighth floor, but also in
other areas of the building, including a specialized
Nanofabrication and Imaging Center (NIC), operated
by the Office of the Vice President for Research.
The NIC is one of the most pristine areas on
campus. It houses a class 100 cleanroom equipped
with a full spectrum of nanotechnology equip‑
ment that will be used to create devices that are
tens of nanometers in size in an environment free
from contaminants.
The neighboring microimaging suite is filled with
modern microscopy instrumentation, allowing visual‑
ization of atomic structures, integrated microcircuits,
neuronal circuits, and more. The advanced tools and
technologies will allow researchers to study samples
in ultra-fine detail and allow them to create large 3-D
reconstructions of specimens.
For Anastas Popratiloff, M.D., Ph.D., adjunct
associate professor of anatomy and regenerative
biology at SMHS, combining all of GW’s microscopy
resources under one roof is a great approach.
“I believe in technology. I believe technology
can change perceptions,” he says. “This is the kind of
thing that’s going to move us forward.”
The new labs and technologies allow for infra‑
structure that will expand the work and research GW
does, he says. In addition, it encourages sharing of
the equipment between students and faculty in the
Columbian College of Arts and Sciences, the School
of Engineering and Applied Science, and SMHS.
“I think collaboration now is becoming more and
more important,” Popratiloff says.
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BY CAROLINE TRENT-GURBUZ

Brad Jones, Catherine Bollard, and Douglas Nixon were sitting around
Bollard’s office one morning, bouncing ideas back and forth. Other
“collaboratories” — teams of researchers and institutions united under
a National Institutes of Health (NIH) grant with a goal of curing HIV/
AIDS — had devised clever, to-the-point names for their projects:
CARE (Collaboratory of AIDS Researchers for Eradication), DARE
(Delaney AIDS Research Enterprise), and the even more straightforward
“defeatHIV.” The trio wanted to do their mission justice.

guess maybe a week before that, I was having a
conversation with a friend of mine who’s living with
HIV, who has followed the research very closely,”
recalls Brad Jones, Ph.D., assistant professor of
microbiology, immunology, and tropical medicine at the GW
School of Medicine and Health Sciences (SMHS). “He said, in
a moment of weakness, that he wasn’t sure if he believed there
would be a cure for HIV.”
The word stuck with Jones. Believe. He played around
with possibilities and was surprised at how easily he could
create a spell-out for the acronym reflecting the goals of
the collaboratory: “Bench-to-Bed Enhanced Lymphocyte
Infusions to Engineer Viral Eradication.”
“Our program goes all the way from basic science to
the bench to the bedside: We’re taking these lymphocytes,
which is another word for immune cells, so-called T-cells, and
enhancing them, putting them back into the patient, and trying
to eradicate infection,” he says. “It just clicked.”

Best Science

The BELIEVE grant, as it’s now known, is a multimilliondollar grant awarded as part of the second iteration of the
NIH Martin Delaney Collaboratory: Towards an HIV-1
Cure. Established in honor of late AIDS activist Martin
Delaney, the five-year grant is designed to draw researchers
out of their silos, pairing them with colleagues across the
country. The grant also puts researchers together with private
companies, in this case immunotherapeutic company Altor
BioScience Corporation (Altor) as well as Torque Therapeutics
(Torque), a biomedical engineering company, to accelerate the
bench-to-bedside process.
“Part of the fun of this [grant] was finding partners that
we think are doing really exciting, cutting-edge studies with
products that we hope could also be of value in the HIV cure
area,” explains principal investigator Nixon, M.D., Ph.D., chair
of the Department of Microbiology, Immunology, and Tropical
Medicine and Walter G. Ross Professor of Basic Science
Research at SMHS. “It’s something important, for us to be
working with industry partners.”
It’s just as exciting, he adds, to find other researchers doing
the “best science,” a critical aspect of the inclusive, cooperative
nature of the grant. “I think one of the things about this sort
of team-type science is that no one group has all the expertise
necessary, so you actually welcome the opportunity to reach
out and find the best people.”

Driving the Research

To keep the research on track — and the communication
flowing — the BELIEVE Executive Committee, composed
of Nixon; Jones; Bollard, M.D., professor of pediatrics and of
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microbiology, immunology, and tropical medicine at SMHS;
and Alan Greenberg, M.D. ’82, M.P.H., director of the D.C.
Center for AIDS Research, and professor and chair of the
Department of Epidemiology and Biostatistics at the Milken
Institute School of Public Health at GW, will track progress
among the teams.
“The way we’ve structured this grant, all of the different
objectives have milestones and timelines that they need to
meet,” explains Jones. If all of those milestones are met, the
grant value could reach $28 million.
In essence, GW, in running the management and
operations section, is the engine pulling the rest of the train.
“Obviously,” Nixon adds, “you need all the parts to work
together for a functioning unit. We have to keep all of our
subcontracts in order, we have to keep the milestones on track,
we have to have these compulsory meetings … we’ve got a lot of
administrative components that are really important.”

Armed Against Infection

With GW leading the way, the BELIEVE grant has several
initial research foci: enhancing the killing capability of
HIV-specific T-cells, expanding the functions of natural killer
cells, helping the killer cells find HIV in the body more easily,
and bringing the best combinations into clinical studies.
“The overall idea is that the different foci come together
to turn the immune system into a kind of weapon against the
HIV reservoir,” explains Jones.
Although antiretroviral therapy can help reduce HIV levels,
it cannot reach dormant, or hidden, HIV in the latent cells,
which can reactivate and start the infection cascade over again.
Previous researchers have used “kick and kill” strategies to try
to eliminate infected cells, but their efforts have been limited,
owing to the inability of the immune system to reduce the viral
reservoir, or kill enough of the infected cells. The BELIEVE
teams will use their expertise — and the products of Altor and
Torque — to define the mechanisms that have prevented the
immune system from completely clearing the infected cells.

Enhancing the T-Cell

The investigations at GW and clinical partner Children’s
National Health System, led by Jones and Nixon, focus
specifically on the grant’s first research target: making the most
of the T-cell’s killing power.
“My goal is to figure out how we can best aim killer T-cells
against HIV-infected cells,” says Jones. “[HIV cells] have ways
that they usually hide from the immune system, but we want
to expose them. Other people have strategies they’re working
on to send these T-cells to the right parts of the body and to
directly enhance the function of the T-cells, but I’m really
working on how to direct them properly.”

In other words, Jones is focusing more on the “kill” side of
“kick and kill.” To accomplish his goal, Jones is working closely
with Altor, which has developed a molecule known as ALT-803.
This molecule reverses HIV latency in cells and, when given
as a therapeutic, activates T-cells and natural killer cells
throughout the body.
“What’s unique about Altor’s molecule is it actually wakes
up hidden HIV and enhances the ability of the immune system
to kill those reactivated cells, so we think it’s really unique and
exciting,” explains Jones, adding that the company’s scientists
also bring a great deal of enthusiasm and insight to the project.
ALT-803 is currently in clinical trials for cancer, which makes
establishing similar trials using the molecule for HIV/AIDS a
faster, more efficient process.
Torque, on the other hand, has found a way to attach
efficacy-enhancing drugs to cytotoxic T-cells via nanoparticle
backpacks, a delivery method that can help the researchers
precisely coordinate the “kick” with the “kill,” potentially
leading to clearance of the HIV viral reservoir.
Jones is also focusing on a pair of preclinical systems. The
first involves testing the cells of those living with HIV, in vitro.
“We have assays that let us test different ways of eliminating
HIV in the test tube,” he explains. “We need to pass certain
milestones in that kind of controlled setting before we can
expect to have success in the more complicated in vivo setting.”
To connect the test-tube setting to patients, Jones and his team
of investigators will use a unique mouse model as a steppingstone to the clinical phase.
Historically, small animal models have proven a tricky
prospect for HIV researchers because mice cannot be infected
with HIV; rather, researchers create “humanized mice,” or mice
carrying a human immune system. Jones is taking a different
tack: “We’re taking those immune cells from people who have
been on antiretroviral therapy for years, and [we’re] putting them
into mice, so you already have that natural HIV reservoir.”
Bollard’s work, meanwhile, is more translational. Her
research “involves the manufacture of HIV-killing T-cells
and the administration of these novel T-cells to HIV-positive
individuals on antiretroviral therapy given either alone or in
combination with the latency reversal agent ALT-803,” she says.
“We will evaluate the safety of this combination and the efficacy
of this therapeutic approach to clear the viral reservoir.”
She will base the HIV-killing T-cells she’s developing on

the work Jones is conducting in the mice. Then, they’ll give
those cells to patients.
“What’s unique about this grant is the rapid translation
of novel ideas developed at the bench and then getting them
to the clinic,” she says. “So much work is done that is focused
on the mice or the monkey, and [it] never gets any further. It is
refreshing to see such an emphasis on translation to the clinic.”
For Nixon, Bollard and Jones’ work exemplifies the greater
goals of the grant. “We have an ambitious program in which we
would like to be able to move into the clinic in Year Two,” he
says. “We’ll have to see if that’s a possibility, but we’re certainly
going to try and push for that. Our philosophy is best science
plus getting into the clinic as rapidly as possible.”

Broader Conversations

Outside the labs, the grant will prioritize community engagement
through local advisory boards and ongoing communication.
“[It’s not] just teaching the community, [it’s] listening to
people’s expectations about cure research, their fears, their
hopes, so that we can be sure that we’re responsive to the
people that we’re trying to help,” explains Jones.
Washington, D.C., in particular, has had some of the
highest rates of HIV in the nation, according to Greenberg,
and the grant helps establish the nation’s capital as “one of the
focal points for NIH-supported HIV cure research,” he says,
which is vital for the community.
Working with the community will also help the team
address misconceptions about what a cure could look like;
taking a pill or two, Jones says, is not yet on the horizon.
What is available now, however, are the highly customizable
procedures that the BELIEVE grant is pursuing. “There are
a lot of approaches, like ours, that involve donating cells that
are manipulated and then reinfused into individuals,” he
says. “We want to be responsive to the community to make
sure that in their perspective, the cures that we develop are
a significant improvement over the current option, which is
daily antiretroviral therapy. We want to make sure that we’re
engaging in a dialogue at all steps of the process.”
With that conversation in mind, Jones adds that his friend,
representative of the community, isn’t quite a believer — yet.
“He does [know about the grant and the work we’re doing],”
says Jones. “He’s quite touched that his comment became part
of this large effort.”

“We want to be responsive to the community to
make sure that in their perspective, the cures that
we develop are a significant improvement over the
current option, which is daily antiretroviral therapy.”

GOING
EVERYTHING IS
INFORMATION:
DATA IS BEING
COLLECTED ALL
AROUND US, AND
WE KNOW IT.
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BIG

BY ERIC BUTTERMAN

It’s happening at the checkout line when
we get that discount for using our grocery
store rewards card — and the store is
learning our preferences in return.
Health care services may not be
marketed to us the way products in the
grocery store are, but a mountain made
up of medical records has appeared
in the virtual world, and it’s growing
exponentially every year. At the core of
that mountain runs a rich vein waiting to
be unearthed — medical data — and that
digital ore offers all of us the chance for a
healthier future.
Important big data contributors
at GW School of Medicine and Health
Sciences (SMHS) are looking to mine
that data and refine it into a most
precious resource: innovation.

DEFINE BIG

Big data is a techno-term that frequently
gets tossed around. But what is big
data exactly? How big is big? With the
expansion of technology into our daily
lives, whether it’s our smartphones;
the radio-frequency ID tags that track
our packages, our pets, and more;
genomic data; or our electronic medical
records, information is piling up at a
dizzying pace. According to computing
giant IBM, we’ve reached the point at

which society is generating between
two and three exabytes of information
daily. To put that into perspective,
your top-of-the-line laptop might
boast 500 gigabytes, or half a terabyte,
of hard drive space; an exabyte is 1
million terabytes.
For Raja Mazumder, Ph.D.,
associate professor of biochemistry and
molecular medicine at SMHS, what
big means is beautiful. “Most of the
time with big data, there are certain
technologies such as next-generation
sequencing, which produces a lot of data.
But how much data? I heard in a talk that
conceptually it costs millions of dollars
to put a satellite into orbit producing
x amount of data, but it doesn’t cost
millions of dollars to purchase a
sequencing machine to generate an
equivalent amount of genomic data.”
And, when it comes to the medical
field, where the data is coming from
isn’t the question. It’s really where isn’t it
coming from.
“It’s practically all over,” Mazumder
says. “Some of it still is coming
the old-fashioned way — a health
practitioner inputs medical information
— but quite a bit is being generated by
medical instruments working directly
with software generating a vast amount
of genomic data, for example.”

GETTING
“INFORM”ED

At the core of big data in medicine are
two vital disciplines, bioinformatics
and medical informatics. Let’s start
with bioinformatics.
“Bioinformatics, in our area at the
school, is dry lab technology, which
means we analyze biomedical and
biology-related data and use algorithms
to analyze it and come up with methods
to process, store, and compute it,”
explains Mazumder. “And we share the
data and define security [protocols] to
even work with it.”
Mazumder co-directs the HIVE
project, which stands for Highperformance Integrated Virtual
Environment, a collaboration between
his group and the U.S. Food and Drug
Administration. The project is a dynamic
cloud system for bioinformatics sequence
data analysis focused on harnessing
next-generation data sequencing; more
recently, his group has also been working
on proteomic data analysis.
In fact, multiple bioinformatics
projects at GW focus on trying to
standardize computations. “Standardized
means, for example, you have a vaccine
sample and you are producing that
vaccine in your company all the time,”
Mazumder says. “But how do you know
from Batch 1 to Batch 2 that you still have
just the vaccine and that contamination
hasn’t occurred? Once you analyze
[gene-sequence data], then you can say
in a particular sample that you have the
all-important pure culture of vaccine and
no mutations that are detrimental.”
The biggest challenge for nextgeneration sequencing data analysis is the
ability to scale up. This issue can come
into play if, for instance, a patient has the
hepatitis C virus and you want to know
the genotype of that virus, Mazumder
explains. Determining the genotype can
be difficult because in the case of hepatitis
C, the illness is chronic; it can create
subclones of viruses in a patient, and the
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same patient can be infected more than
once in a lifetime. “Sequencing the virus
from one patient one time isn’t tough,
but when you get 50 to 100 samples, the
computers and the algorithms available
are not sufficient and, therefore, they
require scaling up,” he says.
In other words, as researchers move
to the high-throughput sequencing
machines, the amount of data produced
can be huge.
“With the bioinformatics we’re
specifically working on — if, say, a
patient has a mutation in position 53 in
a specific protein, so what?” Mazumder
says. “But the hope is that if we can have
additional pieces of information through

complementary discipline.
“There are many definitions, but
the gist of medical informatics is that
it’s about using information technology
to improve medical research, medical
care, and health care delivery; basically
applying data science, information
science, and technology to improve
health care,” says Zeng. “We use
information science and computer
science methods to improve aspects of
the biomedical research or biomedical
science, even clinical research.”
The amount of data to choose from
is practically equivalent to the raindrops
in an endless monsoon.
“You have to be amazed at all the

that you just don’t see in a clinical trial …
When looking at medical records, you
can go back 15, possibly even 30 years.”
The numbers say medical
informatics’ reach looks to be expanding.
According to the 2014–24 projections on
the Bureau of Labor Statistics website,
medical records and health information
technicians will see 15 percent growth in
employment. “We’re just at the start of
what can be done,” Zeng says.
In the end, how do medical
informatics and bioinformatics best
complement each other? “I think what
will happen is hospitals will start having
their own databases of genomic sequence
data,” Mazumder says. “Then, the

“
W E’RE JUST AT THE
START OF WHAT CAN
BE DONE,” ZENG SAYS.
comprehensive data integration for the
hepatitis C virus, then we can say that
this position codes for this protein and
there is already a drug that targets that
mutation. And if you have that, now
you have actionable information from
a research perspective. And then … you
can look at a treatment perspective.”

COMPLEMENTARY
COMPUTING
Yet there’s still that other major
player to consider in big data: medical
informatics. Some may view it as a rival
to bioinformatics, competing interests
in a battle for health information.
Medical informatics, to Qing Zeng,
Ph.D., professor of clinical research and
leadership at SMHS, isn’t a competitor
to bioinformatics but rather a potential
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data available for medical informatics,”
Zeng says. “It’s the collection for routine
clinical trial patients, it’s the medical
record, and even a biosample collected.”
One form that medical informatics
has taken at SMHS is the Otsuka Data
Mining project. “Otsuka is a company in
the pharmaceutical space,” she explains.
“They were interested in psychiatric
disease and wanted us to look at aspects
such as schizophrenia and bipolar
disease [to predict outcomes].”
The team identified more than
1 million patients who fit the criteria
they were focusing on. “Remember that
clinical data tends to be more diverse
than clinical trial data because [patients
in the latter group] tend to be younger
and healthier,” Zeng says. “We do a
retrospective analysis on data sets and
can pick a large amount of information

medical informatics data will not only
use electronic health records, it will use
genomic health data that is continuous.”

RESPECT
THE PATIENT

Still, when you combine a seemingly
nonstop pipeline of statistics and
something as personal as health
information, there is risk. “I think we
will see some changes in years to come
in how patients have access to data, that
they have access and can do what they
want with data,” Mazumder says. “My
perspective is I think the data should
belong to the patient. We need to make
strides, but we have to remember, at the
least, the dignity of the patient and a
sensitivity to what these statistics mean
to them.”

FROM ITALY TO AMERICA
BY CAROLINE TRENT-GURBUZ

C

arolina Panico, M.D., Ph.D., laughs as she describes telling
her father she had become an American citizen. “I called my
dad, I told him, ‘Dad, I’m an American today!’ and he said,
‘You were American before.’”
Panico, a native of Naples, Italy, originally came to the United
States during her Ph.D. program, when she was a student at the
Second University of Naples. “I had the chance to come to the
States to visit Georgetown University,” she says. “After my visit, the
director of the laboratory in the Department of Nephrology there
became my co-mentor for my Ph.D. thesis.”
Panico conducted most of her research in renal and
cardiovascular pathophysiology at Georgetown University, where
she stayed until moving across town to work in the Department
of Biochemistry and Molecular Medicine at the GW School of
Medicine and Health Sciences (SMHS). It was there that she
started exploring regulatory affairs.
“I heard about the regulatory affairs [program at GW]
because this has become one of the hot topics in the last few years,”
she says. “It sounded very exciting to me, and I applied, and I was
accepted.”
The program was a good fit: “It integrates elements of
global regulatory strategy across the entire curriculum, and
you get an understanding of the regulation for the development
of [a] spectrum of products, like drugs, devices, biologics,” she
explains. “Also, you acquire the ability to work in an international
environment, which is very important to me.”
The program also offered Panico insight, she says, into areas
somewhat neglected during traditional education: entrepreneurial
thinking and the rules and regulations of medicine development.
The latter allowed her to gain greater understanding of the benchto-bedside process, while the former is opening up new potential
career options — possibly sooner rather than later.
“I have some very good news,” Panico announces. “There
is a fellowship I applied to, the Federal Drug Administration
Commissioner’s Fellowship, which is in regulatory science, and I
actually was selected.”
Panico attributes her selection for the fellowship directly to
her experience in the SMHS Regulatory Affairs program; she was
able to meet with several experts through GW, and her most recent
classes, she says, helped her perform well during the interview.
The fellowship will keep her in the Washington, D.C. area,
and although she continues to miss her family and best friends in
Italy, she has found one bright spot in the city that has become her
home: a Neapolitan pizza place in her neighborhood.
“There are great places now where you can eat very good
Neapolitan pizza; there’s one in Takoma Park especially,” she says.
“I’m a little picky about my pizza.”
GWMEDICINEHEALTH.COM
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The One Who
Understands

S

BY CAROLINE TRENT-GURBUZ
tephanie Cho’s office, at the end of a long, U-shaped
corridor, is calm and soothing. She speaks enthusiastically about her profession — she’s a PGY IV chief
resident in psychiatry at the GW School of Medicine
and Health Sciences (SMHS) — and her goal is clear: to treat
those in need.
“I knew from a young age that I wanted to be a doctor,”
Cho recalls, settling into a chair near her desk. The daughter of
Korean immigrants, she grew up in the suburbs of Los Angeles.
When she was younger, her father suffered from heart problems,
an experience that “sparked [her] interest in medicine.”
In pursuit of the “best science education” she could get,
Cho moved from coast to coast: first, to the Massachusetts
Institute of Technology (MIT) and then, following graduation,
back to southern California, where she earned her M.S. and
M.D. degrees from Loma Linda University. Now, she’s nearing
the end of her psychiatry residency at SMHS, and her next step
is a fellowship in psychosomatic medicine.
“Psychosomatic medicine … is basically psychiatry [for]
the medically ill,” she explains. More specifically, the discipline
connects psychological and behavioral factors with their impact
on health and disease. “That brings it all together for me,” says
Cho. “As I went through medical school and residency, I realized
that this is what I always pictured as being a doctor: being aware
of a patient’s medical problems and how they are affecting their
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life and the quality of life they have.
That’s what I’ve begun focusing more and
more on throughout residency.”
That kind of focus — how someone’s
health, mental or physical, affects quality
of life — goes back to her early days at
MIT, when she was rushing a sorority.
“One thing that I realized when I went
through the recruitment process was
it’s a really a stressful situation; you’re
being put into a social situation where
you’re not judging each other, but you’re
trying [to find] a really great fit,” she says.
“Especially in the beginning of college, in
that age of adolescence, it becomes very
much about, ‘Am I good enough? Do they
like me?’”
Cho, who joined Alpha Chi Omega,
became a recruitment counselor and
reached out to MIT mental health. Together, they brought
in psychiatrists and therapists to train counselors on how
to help students process what could be an emotionally
grueling experience.
A few years later, as part of a clerkship, Cho helped another
group of students deal with a potentially draining undertaking:
treating addiction patients with empathy. “This was very
interesting to me in general, because it’s not just psychiatrists
who deal with it; really, all physicians need to address addiction
in their patients,” she explains. What she found was that
medical students tended to be more empathetic to certain
subsets of patients, such as veterans. With patients who grew
up in more privileged environments, medical students were
actually less empathetic. Cho is now working on a project to
help address how students feel or don’t feel empathy toward
patients with psychosomatic illnesses.
“I feel very strongly that all doctors should have [empathy]
cultivated in them and really developed in them as they go through
medical school — and be allowed to identify and be honest about
it when they don’t feel empathy,” she says. “[It’s about] really being
able to allow us as physicians to identify and maintain a strong
sense of empathy without letting it drown us at the same time.”
Cho plans to continue shaping empathy in all medical
students, particularly when it comes to psychiatry. “I want to
become a clerkship director and teach psychiatry to medical
students,” she says.
As she explains, she doesn’t want to “preach to the choir”;
she wants to make sure every student, regardless of future
specialty, feels comfortable addressing patients’ psychiatric
needs. “Being able to give students that tool kit, to recognize
their own levels of empathy and be able to address that to help
people, that is what I want to do,” she says.

The Power
and Promise
of Medicine
BY CAROLINE TRENT-GURBUZ
arcus Mitchell, clad in green scrubs and his GW
School of Medicine and Health Sciences white coat,
has only a short break after finishing his rounds at
GW Hospital to talk about the meandering path
he’s taken in medicine.
The D.C. native and fourth-year M.D. student initially
planned on pursuing emergency medicine, but “although I have
so much respect for the field, I quickly found out that it wasn’t
for me,” he says, laughing. “Had you told me I’d be applying to
anesthesiology last year, I probably wouldn’t have believed you.
It’s something that just kind of developed.”
Anesthesiology, he explains, pausing to sip from his to-go
coffee, is procedural and hands-on, with moments of intensity.
It incorporates pharmacology and physiology, which appeals
to him, and it allows him to interact more closely with his
patients, giving them his undivided attention. “I like that even
though [during] your interaction with your patients, their
conscious awareness is brief, it’s really powerful, especially
during the pre-op encounter.”
That kind of interaction is central to Mitchell’s brand of
medicine: He cares about his patients, about his community,
and about his future clinician colleagues. “I want to be
involved with and serve an underserved community; that’s
really important to me, that I have diverse patients who come
from all over and have various socioeconomic statuses,” he
explains. Already a veteran of medical mission trips to Haiti
and Ecuador, Mitchell plans to bring his anesthesia skills to
wherever they’re needed most.
And at home, he plans to give back. When Mitchell
first entered SMHS, he was awarded the Power and Promise
scholarship, designed to alleviate the financial burdens
for GW’s best and brightest. It’s helped relieve his student
debt — and inspired him. “It actually encourages me to
give back as an alumnus,” he says. “I definitely want to have
my own scholarship fund so I can give back and help some
[unsuspecting] student who’s doing a good job.”
With that, Mitchell stands up, coffee cup still in hand, to
head back to the hospital, where he’ll remain on call until 9 a.m.
the next day.

M

The fam. #gwmed #blackmeninmedicine
75 WEEKS AGO

First operation of MS3 was a success!
59 WEEKS AGO

Fourth-year M.D. student Marcus
I can truly say that I had some great
times this year #gwmed
121 WEEKS AGO

Mitchell is an avid Instagram
user.
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FACULTY NEWS
The Heart–Brain
Connection

Take a Breather
Asthma in children living in the inner
city can be especially severe, and
research by Stephen Teach, M.D.,
M.P.H., chair of the Department of
Pediatrics at Children’s National Health
System and professor of pediatrics
and emergency medicine at the
GW School of Medicine and Health
Sciences, shows there are distinct
subgroups of asthma patients within
that vulnerable population.
Funded by the National Institutes
of Health, the Inner-City Asthma
Consortium (ICAC), of which Teach
is a member, consists of a group of
investigators from across the country
that focuses on improving outcomes
for inner-city kids with asthma. After
a year of observing more than 600
such children, Teach and his ICAC
colleagues were able to identify five
distinct asthma phenotypes.
The phenotypes found were
lower allergy/inflammation with
minimal asthma symptoms, which
affected 15 percent of participants;
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highly symptomatic asthma (even
with treatment) and lower allergy
and inflammation, which affected
15 percent; minimal asthma and hay
fever symptoms, with intermediate
allergy and inflammation, which
affected 24 percent; higher asthma
and hay fever symptoms and allergy
inflammation, which affected 30
percent; and the most symptomatic
asthma with the highest serum lgE,
blood eosinophil count, and allergen
sensitizations, which affected
16 percent.
“For the first time, we’ve been
able to describe in very elegant, very
complete fashion various subgroups
within this population, and going
forward, these subgroups are likely
to guide studies of targeted therapy,”
Teach said.
The findings were published
recently in the Journal of Allergy and
Clinical Immunology, along with two
other studies by ICAC researchers on
inner-city pediatric asthma.

Between the heart and brain lie a
series of connections — sometimes
figurative, in this case literal — that
researchers believe are the key
to helping the millions of patients
who suffer from heart failure. David
Mendelowitz, Ph.D., vice chair and
professor in the Department of
Pharmacology and Physiology at the
GW School of Medicine and Health
Sciences, and Matthew Kay, D.Sc.,
associate professor in the Department
of Biomedical Engineering at the GW
School of Engineering and Applied
Science, will examine that connection,
thanks to a four-year, $1.6 million grant
from the National Heart, Lung, and
Blood Institute.
The two will study ways to restore
parasympathetic activity — which
is cardiac protective — to the heart
through oxytocin neuron activation,
which could improve cardiac func‑
tion during heart failure. Heart failure
affects both neurologic and cardiac
function; Mendelowitz will focus on
the neuroscience behind heart failure,
whereas Kay will use high-speed
optical assessments of heart function
to identify how oxytocin nerve activa‑
tion benefits the heart.

Excellence in Care
John Larsen, M.D., professor of obstetrics and gynecology and former chair of the
department at the GW School of Medicine and Health Sciences, recently marked
his decades-long career with a prestigious award: the 2016 Hellman Midwifery
Partnership Award. Larsen, who has been a fellow of the American College of
Gynecology (ACOG) since 1976, received the ACOG recognition for having
demonstrated outstanding support for midwifery through advocacy for
women; excellence in clinical, education, and research endeavors; and
leadership in collaborative practice. Larsen has played a leading role in
integrating midwifery care into GW Hospital, and he helped expand
access to evidence-based comprehensive care.
The award is jointly sponsored by the American College of Nurse
Midwives (A.C.N.M.), the A.C.N.M. Foundation, Inc., and the Midwifery
Business Network.

Section Selection

Health Equity and Cultural Sensitivity
With a pair of grants totaling more than
$1 million, the George Washington
University Cancer Center (GWCC)
continues to advance health equity
across the Washington, D.C. area. From
the Pfizer Foundation, GWCC received
$1 million to promote patient-centered
cancer care and increase patient health
literacy and cultural sensitivity. The
project, which provides resources for
patients and health care providers
to have improved conversations, will
examine how gender, gender identity,
race, ethnicity, sexual orientation, and
income affect the patient–provider

relationship.
The second grant, $100,000
from Susan G. Komen, given as part
of a local investment of more than
$1 million, will fund a multifaceted
project designed to reduce cancer
disparities in the lesbian, bisexual,
and transgender (LBT) community
in Washington, D.C. The goal of the
project is to increase LBT individuals’
health literacy and engagement in
health care and help health profes‑
sionals provide more sensitive care to
LBT patients at risk of or diagnosed
with breast cancer.

Pedro A. Jose, M.D., Ph.D., professor
of medicine and of pharmacology and
physiology at the GW School of Medicine
and Health Sciences, was elected to
serve as chair of the Hypertension and
Microcirculation Study Section at the
National Institutes of Health (NIH).
The study section reviews grant
applications involving basic and applied
aspects of cardiovascular regulation
with a focus on microcirculation, the
pathogenesis of hypertension, and the
physiology of blood pressure regulation.
Jose, in his role, will facilitate the review
process, which includes summarizing
the grant reviewers’ discussion and
calling for a final vote to determine the
reviewers’ opinion regarding the scien‑
tific impact of the grant proposal. Once
the grant proposals are reviewed, the
appropriate council conducts a second
round of reviews, and a recommendation
is sent to the NIH for a final decision.
Jose previously served as chair of
the Hypertension and Microcirculation
Study Section from 1996 to 1998, when
it was known as the Cardiovascular and
Renal Study Section B. The scope of the
study section has since narrowed.
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FACULTY NEWS

Teaching and Tuberculosis
Ian Toma, M.D., Ph.D. ’11, M.S.H.S.
’04, associate research professor
of clinical research and leadership,
and of medicine at the GW School
of Medicine and Health Sciences
(SMHS), was selected as a Core
Fulbright U.S. Scholar to facilitate

THE CAMPAIGN FOR GW
SCHOOL OF MEDICINE &
HEALTH SCIENCES

bioinformatics
and genomics
education and
to conduct a
research project
in Moldova.
Genomics
and bioinfor‑
matics are at
the forefront
of molecular
medicine and
public health
fields. Toma
will collaborate
with the State University of Medicine
and Pharmacy of Moldova (SUMPH)
to develop an educational program
in bioinformatics and genomics for
medical students, residents, and
local scientists. By developing this
program, Toma will not only help
raise the capacity of SUMPH in this

area, but also foster the collabo‑
ration of students, faculty, and
scientists with SMHS and other
international partners.
Toma will also initiate a joint
SUMPH/SMHS research collaboration
between faculty and scientists on
genomic aspects of tuberculosis (TB)
and its multidrug resistant (MDR-TB)
forms. The project, titled “MDR-TB
Results from Unmasking of Resistant
Strains from the Total Mycobacteria
Population by Antibiotics,” will look at
the genomic profiles of patients diag‑
nosed with TB and strains isolated
from patients in Moldova. The goal of
this research is to create an accurate
and simple genomic test to deter‑
mine how the patients respond to
treatment and whether patients are at
risk of developing the MDR-TB forms,
which are often missed and hard
to diagnose.

Support the School
of Medicine &
Health Sciences
By advancing our four-part mission — to teach,
heal, discover, and serve — George Washington
University‘s (GW) School of Medicine and Health
Sciences (SMHS) seeks to change lives for the better.
As part of GW’s $1 billion philanthropic campaign
— which supports students, enhances academics,
and breaks new ground through capital projects
and research — your gift enables SMHS to make a
positive impact in the community, the country, and
the world.

Join us in making history
go.gwu.edu/makehistorysmhs

Thymectomies and
Myasthenia Gravis

A Culture of Collaboration
Gaetano Lotrecchiano, Ed.D., Ph.D.,
assistant professor of clinical research
and leadership and of pediatrics at the
GW School of Medicine and Health
Sciences (SMHS), is spearheading a
new seminar, “Creating a Culture of
Collaboration at George Washington
University,” or C3@GW. The seminar
brings together a cross-disciplinary
community of GW expert faculty with
an interest in scientific collaboration
and connects them to regional and
national partners and experts.
Elements of C3@GW include “think
tanks,” or communities representing
GW, local institutes, and federal
government stakeholders, as well
as short- and long-term discussions
emphasizing the mechanisms of scien‑
tific collaboration: developing and
educating team scientists; measuring
team effectiveness; technologies for
collaboration and scholarship informet‑
rics; organizational supports; faculty
reward and recognition for collab‑
orative activities; and issues crossing
cultural, ethnic, and gender boundaries
in science.
C3@GW is a collaborative venture
with the Clinical and Translational
Science Institute at Children’s National
Health System, the SMHS Department
of Clinical Research and Leadership,
and additional experts from the GW
community, other universities, and
government agencies.

Henry Kaminski, M.D., chair of the
Department of Neurology and
Meta Amalia Neumann Professor of
Neurology at GW School of Medicine
and Health Sciences, has found that
removing the thymus effectively
reduced myasthenia gravis (MG)
patients’ muscle weakness, as well as
the need for immunosuppressive drugs
and hospitalizations.
“While surgery is expensive and
not without risk, this research will

Leading the Charge
Sally A. Moody, Ph.D., professor and
interim chair of the Department of
Anatomy and Regenerative Biology
at the GW School of Medicine and
Health Sciences, is on the rise: She was
recently elected to a two-year term as
vice president, and later president, of
the Society for Craniofacial Genetics
and Developmental Biology (SCGDB).
Moody, who has held leader‑
ship positions both internally at GW
and externally, including serving as
program official in developmental
genetics and genomics at the National
Institutes of Health – Eunice Kennedy
Shriver National Institute of Child Health
and Human Development, will bring

empower patients and their doctors
to make informed decisions regarding
treatment,” said Kaminski.
Previous studies have suggested
that removing the thymus may reduce
MG symptoms — droopy eyelids;
blurred or doubled vision; difficulty
talking, breathing, and swallowing;
and neck and limb movement
problems — but Kaminski’s study,
published in the New England Journal
of Medicine, is the first randomized
study of thymectomy in MG patients,
providing clinical evidence of the
benefits of the surgery.

invaluable experience to SCGDB. The
international organization, established
in 1975, is committed to advancing
the knowledge, health, and preven‑
tion of craniofacial disorders through
education and research. The goal of
the organization is to decrease the
incidence of birth defects affecting the
craniofacial region.
Moody was also part of a team of
researchers whose study, “Label-free
Quantification of Proteins in Single
Embryonic Cells with Neural Fate in the
Cleavage-Stage Frog (Xenopus laveis)
Embryo Using Capillary Electrophoresis
Electrospray Ionization High-Resolution
Mass Spectrometry (CE-ESI-HRMS),”
was featured on the cover of Molecular
and Cellular Proteomics.
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Salute to Sarani
Babak Sarani, M.D. ’97, associate
professor of surgery at the GW School
of Medicine and Health Sciences,
has completed a neat hat trick: three
awards in three years. In 2014, Sarani
was the faculty inductee for the Gold
Humanism Honor Society, which recog‑
nizes those who have demonstrated
excellence in clinical care, leader‑
ship, compassion, and dedication to
service. The next year, Sarani, chosen
by third-year medical students, earned
the Golden Apple Award for Teaching
Excellence. This year, he was selected
by the members of the Emergency
Medicine Residency Class of 2016 as
the recipient of the Residents’ Choice
Award, Off-Service Attending of the
Year, for trauma surgery.

Taking Aim at New
Targets for Myasthenia
Gravis Treatment
Linda Kusner, Ph.D., associate research
professor in the Department of
Pharmacology and Physiology at
GW’s School of Medicine and Health
Sciences, received a multi-year Muscular
Dystrophy Association research grant
of nearly $300,000 to provide a new
fundamental understanding of the basic
mechanisms of autoimmunity and to
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validate a new therapeutic target for
myasthenia gravis (MG).
Kusner aims to develop a therapy
for MG that might lessen or eliminate
the need for corticosteroids, the current
standard of care. With colleagues, she
discovered a protein called survivin
present in MG-affected cells that the
group believes supports the pres‑
ence of autoreactive immune cells by
allowing them to escape cell death.
In studies that targeted the protein,
Kusner and her team observed a reduc‑
tion in the levels of antibodies in the MG
disease process.
In her new work, Kusner will analyze
thymus tissue from MG patients as well
as from healthy individuals to deter‑
mine whether the survivin protein is
present in both. Kusner’s team also will
evaluate survivin-based therapeutics
in an MG rodent model to assess the
therapeutics’ ability to improve observ‑
able weakness, decrease the expression
of autoreactive immune cells, decrease
acetylcholine receptor-specific anti‑
bodies, and decrease damage to the
nerve–muscle junction.

Getting On Board
Eduardo M. Sotomayor, M.D.,
inaugural director of the George
Washington University Cancer Center,
was elected to serve on the board
of directors of the Association of
American Cancer Institutes (AACI).
Sotomayor began his three-year term
in October 2016.
The AACI comprises 95 leading
cancer research centers in North
America — including National
Cancer Institute (NCI)-designated
cancer centers and academic cancer
research programs that receive
NCI support.
Sotomayor was elected to
this prestigious group along with
Karen Knudsen, Ph.D., B.S. ’91, who
is the third director of the Sidney
Kimmel Cancer Center at Thomas
Jefferson University in Philadelphia,
an NCI-designated cancer center
since 1995.

Support for Hookworm Vaccine Trials
Researchers from the GW School of
Medicine and Health Sciences (SMHS)
received a $2.1 million U01 grant from
the National Institutes of Health to
launch a Phase 1 clinical trial to test a
new hookworm vaccine in Brazil. This
effort is the latest in a series of tropical
vaccines created by SMHS researchers.
This clinical trial — led by co-prin‑
cipal investigators Jeffrey Bethony,
Ph.D., professor of microbiology,
immunology, and tropical medicine
at SMHS, and David Diemert,
M.D., associate professor of
microbiology, immunology,
and tropical medicine
at SMHS — will be the
first time immune
interference has
been tested using

new antibody profiling methods and
B-cell immunology.
“We have two separate vaccines
for hookworm that have each been
tested on their own,” said Diemert.
“We would like to combine them into
a single product, so we have one vial
offering the greatest protection against
hookworm.”
A parallel clinical trial, funded by
the European Commission, is underway
in Africa; in this trial, all volunteers
have been given both vaccines. In
Brazil, some volunteers are given
one of the vaccines, and others are
given both vaccines, creating greater
opportunities for comparison. For the
clinical trial, GW is partnering with
the Fundação Oswaldo Cruz in Brazil,
University of California–San Francisco,
and Johns Hopkins University, as well
as the Sabin Vaccine Institute.

prevalent in HIV/AIDS populations.
The study, titled “Blimp-1
Mediated CD4 T-Cell Exhaustion
Causes CD8 T-Cell Dysfunction During
Chronic Toxoplasmosis,” is funded by

a grant from the National Institutes
of Health.
Khan recently received the SMHS
Distinguished Researcher Award for his
work on toxoplasmosis.

T-Cell Exhaustion and
Toxoplasmosis
New research critical to treatment
for chronic toxoplasmosis, one of
the most common parasitic diseases
worldwide, was published in the
Journal of Experimental Medicine.
A team of researchers from the
GW School of Medicine and Health
Sciences, led by Imtiaz Khan, Ph.D.,
professor of microbiology, immu‑
nology, and tropical medicine,
identified a connection between
CD8 T-cell exhaustion and CD4 T-cell
exhaustion. They also determined
that CD4 T-cells can be regulated
by Blimp-1 protein expression. The
discoveries could lead to new treat‑
ment possibilities.
Toxoplasmosis is a parasitic infec‑
tion that in healthy adults does not
typically cause symptoms. Among
pregnant women and the immunosup‑
pressed, however, the consequences
can be severe. This disease is especially
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Turn your Deed into
A GOOD DEED

If you want to create a lasting legacy at the GW School of Medicine and Health Sciences,
consider a gift of real estate. Your donation can support medical student scholarships,
advance powerful research initiatives, or provide valuable funding for community or education
programs. What’s more, by donating real estate to GW, you can achieve peace of mind and
receive significant financial benefits for yourself or someone else.
There are many options for donating your home, second home, commercial building, raw land or other
real estate to GW. Depending on the nature of your gift and your objectives, you could:
•
•
•
•
•

Avoid capital gains taxes on appreciated property
Eliminate the burden of maintaining and paying for the property
Provide yourself with an annual income
Continue to use the property for the remainder of your life
Reduce your estate and income taxes

Please contact us to discuss the benefits of a real estate gift for your specific situation.

For more information, please contact:
Adam Lewis
Senior Associate Director of Planned Giving
202-994-7657 or aslewis@gwu.edu

The George Washington University
Office of Planned Giving – Real Estate
2033 K Street, NW, Suite 300
Washington, DC 20052

Prior to acceptance of each potential gift of real estate, the University’s Gift Acceptance Committee reviews the administrative and
financial costs, liabilities, and benefits of the gift. This review assures the George Washington University Board of Trustees that the gift
advances the university’s mission and values and that it is financially sound.
DAR2860
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Finding
Promise
in Cancer
Research
BY CAROLINE TRENT-GURBUZ

W

hen Milwaukee, Wisconsin, native Heather
Levin, M.D. ’15, starts talking about research,
her enthusiasm and delight builds, and it’s
clear how much the work means to her.
“It’s really exciting for me to have this research year,”
she explains.
Levin, with help from primary investigator Lopa
Mishra, M.D., director of the Center for Translational
Medicine and professor of surgery with the GW School
of Medicine and Health Sciences, applied for the newly
established Albert L. Tucker and Elizabeth T. Tucker
Postdoctoral Fellowship earlier this year. The $1 million
grant, available through the Albert L. Tucker and Elizabeth
T. Tucker Foundation, supports the postdoctoral training
program for promising young cancer researchers. This year,
that researcher was Levin.
“Having this award allows me to pursue a research year
before I begin residency, which will allow me to strengthen my
medical background and strengthen my science background
before I start,” she explains.
The fellowship is housed within the George Washington
University Cancer Center, led by Eduardo M. Sotomayor, M.D.
“We are very grateful for the support that has been

provided by the Tucker Foundation,” he says. “It will enable
us to provide valuable training to a fellow who will make a
difference in the field of cancer research.”
Levin, working in Mishra’s lab, is exploring liver cancer,
one of the most common causes of cancer deaths worldwide.
As she explains, there are two strands to her team’s research,
“Targeting E3 Ligases in Liver and GI Cancer.” First, they
identified the TGF-beta pathway, a cellular pathway that
plays a variety of roles in liver cancer, including one as a tumor
suppressant. Second, using the cancer genome atlas, a “huge
catalog of genome sequencing and genetic mutations from
cancer patients,” Levin explains, they found that a specific
enzyme — E3 ligase — was altered in more than 50 percent of
patients with liver cancer included in the atlas.
“Looking at that specific enzyme, it actually targets part
of the TGF-beta pathway for degradation,” Levin says. “The
TGF-beta pathway is playing a tumor suppressive role, and the
E3 ligases are degrading a piece of that pathway [and] stopping
that tumor suppressive role, so we believe that we can target
those E3 ligase enzymes with various treatments. We can
actually restore that tumor suppression role of that pathway in
treating cancer.”
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Grateful to Give
Clinical Care Inspires
Gendron Family to Support
Cancer Research Innovation
Philanthropy has myriad motivations;
there are as many reasons to give as
there are causes in need of support.
For Roger J. and Susan Gendron, the
reasons are simple: first, their son
Theodore is a recent graduate of the
George Washington University (GW)
School of Business, earning a bachelor’s
degree in business administration in
May 2016; more significantly, however,
Susan is a breast cancer survivor under
the care of Robert Siegel, M.D. ’77,
associate center director for education

and training at the GW Cancer Center
(GWCC) and professor of medicine at
the GW School of Medicine and Health
Sciences (SMHS).
“Dr. Siegel is a miracle worker and
has been a comforting source of healing
and inspiration,” Susan says. She adds
that her experiences at the GW Medical
Faculty Associates and at GW Hospital
were exceptional. “The staff, nurses, and
physicians have made my journey much
more bearable due to their compassionate care and professionalism.”
In recognition of the treatment
Susan received from Siegel, the couple
made a $2.5 million gift to GWCC to
establish the Gendron Family Cancer
Research Fund. The fund will support
basic and translational science research,

as well as contribute to pilot research
grants for residents and fellows. “Giving
back is our way of saying thank you,”
Susan says.
“We’re bringing innovative research
to areas in need,” explains Eduardo M.
Sotomayor, M.D., director of GWCC,
director of the Division of Hematology
and Oncology, and professor of medicine
at SMHS. “We are not just repeating
what other cancer centers are doing
— we’re coming with our own set of
unique ideas.”
Thanks to the Gendron family’s
gift, he adds, the opportunities for
collaboration around pilot funding
resources will blossom, “dramatically
increasing our capacity to impact both
cancer research and clinical care.”

For the second consecutive summer,
John D. Evans and Steve Wozencraft
welcomed members of the GW School of
Medicine and Health Sciences (SMHS)
to their Sag Harbor, New York, home
for a special reception to benefit two
SMHS organizations: The Research
Center for the Eradication of HIV
and The Rodham Institute for Health
Care Provider Education to Eliminate
Disparities. This year’s event took place
aboard Evans and Wozencraft’s yacht,
the Waterford.

Support from Sag Harbor
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As a select group of guests cruised
Sag Harbor Bay, Jeffrey S. Akman, M.D.
’81, RESD ’85, vice president for health
affairs, Walter A. Bloedorn Professor
of Administrative Medicine, and dean
of SMHS, as well as Douglas F. Nixon,
M.D., Ph.D., Walter G. Ross Professor
of Basic Science Research and chair
of the Department of Microbiology,
Immunology, and Tropical Medicine at
SMHS, and Jehan El-Bayoumi, M.D.,
RESD ’88, founding director of The
Rodham Institute and professor of
medicine at SMHS, offered updates on
the latest developments at SMHS.

CLASS NOTES
DISTINGUISHED AMONG US: GW School of Medicine and Health Sciences
alumni, André J. Nahmias, M.D. ’57, M.P.H. (left), and Lieutenant General Nadja
Y. West, M.D. ’88 (center), were among the recipients at the 80th Annual Alumni
Achievement Awards ceremony on Oct. 27.
Nahmias, an Emeritus Professor of Pediatrics and Public Health at Emory
University, was honored for his contributions to research, clinical care, education,
and child advocacy. West is the 44th Surgeon General of the United States Army
and Commanding General of the U.S. Army Medical Command.

Alex Jeffrey Mechaber, M.D., RESD
’97, FACP, professor of medicine and
senior associate dean for under‑
graduate medical education at the
University of Miami Miller School
of Medicine, recently received
the Dr. Bernard J. Fogel Chair in
Medical Education for his 18 years of
outstanding service to the school.

Luther W. Brady Jr., M.D. ’48, HON ’04,
B.A. ’46, A.A. ’44, was recently
awarded his seventh honorary degree,
from Complutense University in
Madrid, Spain.

“Alex was my first chief resident,”
recalls Alan Wasserman, M.D., chair
of the Department of Medicine and
Eugene Meyer Professor of Medicine
at SMHS. “I am very proud of his
accomplishments.”

Ira Spar, M.D. ’68, RESD ’75, published
his second book, Civil War Hospital
Newspapers: Histories and Excerpts
of Nine Union Publications (McFarland
& Company, Inc., 2015). The book
— a follow-up to his 2013 work, New
Haven’s Civil War Hospital: A History of
Knight U.S. General Hospital, 1862–65
(McFarland) — examines the founding
and development of internal Union
hospital newspapers, which were
written and published by patients,
during the Civil War. Spar is a U.S.
Army Vietnam War veteran and is a
board member with the Society of Civil
War Surgeons. He is also president of
the Hartford (Connecticut) Medical
Society and a fellow with the American
Academy of Orthopedic Surgeons.

Mechaber is just the second holder
of the endowed chair, named in
honor of former dean Bernard J.
Fogel, M.D., who served from 1981
to 1995.
“I was both surprised and humbled
when I was notified that I would
be receiving the Fogel Chair,” says
Mechaber, who graduated from the
Miller School in 1994. “Bernie was my
dean when I was in medical school,
so to hold the chair named for him is
especially meaningful to me.”
Mechaber’s wife Hilit Mechaber,
M.D., RESD ’98, also completed her
internal medicine residency at GW
and serves as associate dean for
student services at the Miller School
of Medicine.

Kenneth Fisher, M.D. ’68, recently
published a book, Understanding
Healthcare: A Historical Perspective
(Freedom in Health Care, 2016).

Steven E. Cohen, PA-C ’83, joined the
SMHS faculty as a clinical instructor
in the Physician Assistant (PA) Studies
program. Previously, Cohen served as
a senior neurosurgical PA at Suburban
Hospital, a community-based, not-forprofit hospital serving Montgomery
County, Maryland.

Scott Rifkin, M.D. ’85, CEO of
Mid-Atlantic Health Care, won the 2016
EY Entrepreneur of the Year award
in the Maryland region in the growth
category. The award recognizes entre‑
preneurs who demonstrate excellence
and extraordinary success in such areas
as innovation, financial performance,
and personal commitment to their busi‑
nesses and communities.
Lane R. Rosen, M.D., RESD ’97,
medical director of radiation oncology
at Willis-Knighton Health System, was
honored with the 2016 Louisiana State
University–Shreveport Distinguished
Alumni Award.
Mark R. Greenwood, M.D. ’00, was
selected as the new primary care
clinical program medical director
with Intermountain Medical Group.
Greenwood is a board-certified family
medicine physician who has been
practicing at Sevier Valley Clinic in
Richfield, Utah, since 2003, and he has
also served as the medical director in
the medical group’s central rural region
since 2012.
Samantha Brugmann, Ph.D. ’05,
received the Presidential Early Career
Award in Science and Engineering
(PECASE). Brugmann, an assistant
professor of surgery at Cincinnati
Children’s Hospital Medical Center,
was among 105 researchers to
receive the 2016 award, the highest
honor bestowed by the United
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CLASS NOTES
States government on science and
engineering professionals in the
early stages of their independent
research careers.
Jessica Langenhan, M.D. ’05, recently
earned an M.B.A. with honors from the
University of California–Los Angeles
Anderson School of Management,
graduating from the Fully Employed
MBA program in June 2016.
Langenhan was also named associate
medical director of the substance
abuse program at Laguna Treatment
Hospital in July 2016.
Daniel O’Neill, M.D. ’13, will practice
general internal medicine at the
Neighborhood Health Center in
Portland, Oregon, serving as the
anchoring internal medicine physician
for the new clinic site for Portland’s
underserved populations. O’Neill is
a primary care physician specializing
in HIV and LGBT health, who recently
completed his residency training in
internal medicine at Virginia Mason
Medical Center in Seattle.

Randall Owen, M.S.H.S. ’13, PA-C ’13,
has been appointed as a research
fellow in global health and social
medicine at the Harvard Medical
School for 2016–17. Owen, who
completed his physician assistant
surgical residency at the Norwalk
Hospital/Yale School of Medicine, is a
former medical operations specialist
at NASA Johnson Space Center,
where his research interests included
the ethical and policy challenges
surrounding the medical and
surgical care delivery systems being
developed to support long-duration
space missions.
Andrace Deyampert, M.S.H.S. ’14,
was among the recipients of the 2016
U.S. Food and Drug Administration
Outstanding Service Award.
Jeff Farnsworth, DPT ’15, has been
named director of physical therapy at
the National Sports Medicine Institute
in Virginia.

IN MEMORIAM
Nicholas A. Balsano, M.D. ’65
Gilbert D. Barkin, M.D. ’53, B.S. ’49
James P. Burns, M.D. ’49, RESD ’52,
A.A. ’45
John Timothy Chapman, M.D. ’55
Joseph Bernard Credle, M.D., RESD ’72
Paul H. Daines, M.D. ’58, RESD ’78
Justin Adam Dalton, H.S. ’05 (CERT)
Neilson T. Debevoise, M.D. ’56
Andrew M. Diggs, M.D., RESD ’53
Albert F. Esch, M.D. ’54, M.A. ’50, B.S. ’49
Cynthia A. Evans, M.D., RESD ’87
John S. Featherston, M.D. ’46
Edward E. Gahres, M.D., RESD ’59,
M.A. ’51
Joel S. Ganz, M.D. ’61
Warren Gillette, M.D. ’50
Thomas H. Gresinger, M.D. ’61, RESD ’66
William M. Kane, M.D. ’54
Adolphe C. Kiczales, M.D. ’55, A.A. ’49
Jerome H. Komisarof, M.D., RESD ’60

Save the Date!

Harold Lichtenstein, B.S. ’49

REUNION WEEKEND 2017

John Gage Mahaney, M.D. ’54
Douglas B. McMullen, M.D. ’66
Robert Mrkich, M.D. ’63
Manfred R. Nelson, M.D. ’62
Thomas M. O’Neill, M.D. ’65

September 15 –17, 2017
This year we are celebrating the reunions for the M.D. classes from

1967, 1972, 1977, 1987,
1992, 1997, and 2007

Surendra R. Rishi, M.D., RESD ’69
Allan Schonberg, M.D. ’73

See you back
on campus soon!
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Ronald Ottenberg, M.D. ’59, RESD ’67,
B.S. ’56, A.A. ’55
Frederick Turner Reuter, M.D. ’44

Get involved now by contacting
smhsalumni@gwu.edu or (202) 994–7511

Untitled-1 1

Beale H. Ong, M.D. ’59, B.A. ’55, A.A. ’53

11/30/16 2:15 PM

Albert L. Sheffer, M.D. ’56
Leo H. Siegel, M.D. ’43
Charles G. Wellso, M.D. ’53

IN DEVELOPMENT

S

cholarship support is helping many
of our students fulfill their dreams of
becoming health care professionals.
Extraordinary, long-term financial
sacrifices are often required to pursue degrees
in medicine and the health sciences. The debt
burden facing graduates across the country can
be severe. Among GW’s Class of 2016 M.D.
program students, more than half graduated with significant debt, some
with obligations exceeding $200,000. Those are daunting figures.
Likewise, students in the health sciences programs often leave
campus with large debt loads. In a survey of the Class of 2016 physical
therapy and physician assistant students, a sizable percentage reported
six-figure debt.
The high cost of pursuing an education in an expensive city
such as Washington, D.C. limits the school’s ability to recruit top
students, especially those from less affluent families. The availability of
scholarships can address that situation. We want to ensure that when
students face career decisions — such as which specialty to choose
or where to practice — they are free to base those decisions on their
passions and callings, and not on financial anxiety and pressure.
We need to tackle this problem by finding ways to reduce the debt
load. Scholarships are one of the most effective tools for accomplishing
this task. To that end, we are working to raise at least $4.5 million
in new scholarships this academic year through philanthropic
contributions. Our website, smhs.gwu.edu, provides detailed
information on this effort.
GW already offers more than 70 endowed scholarships in the
School of Medicine and Health Sciences (SMHS). The benefactors who
created those scholarships as well as those who contribute to them have
always expressed satisfaction in being able to help others, particularly
students pursuing their dreams in medicine and the health sciences.
We want to ensure that no qualified student is forced to pass
up a career in medicine or the health sciences because the cost of
education is too high. The goal of SMHS is not only to attract the best
and brightest students to GW, but also to help reduce or eliminate
the crushing financial burden that they can face upon graduation. All
alumni and friends are invited to participate in the SMHS scholarship
campaign. For information about supporting our scholarship fund,
please contact Sumana Chatterjee at (202) 994-6724 or schatter@gwu.
edu. Please join us in this cause.
Sincerely,

SMHS Board of Advisors
Stuart S. Kassan, M.D. ’72, FACP, MACR, Co-Chair
Rheumatology; Distinguished Clinical Professor of Medicine,
University of Colorado-Denver School of Medicine; Chief Medical
Officer, Multispecialty Physician Partners; GW Board of Trustees
Lara S. Oboler, M.D. ’95, Co-Chair
Cardiology; Lenox Hill Heart & Vascular Institute
Gary M. Abramson
Partner, the Tower Companies
Christopher L. Barley, M.D. ’93
Internal Medicine; Clinical Assistant Professor of Medicine,
Cornell/Weill School of Medicine
Constance Urciolo Battle, M.D. ’67, FAAP
Pediatrics and Public Health
Luther W. Brady Jr., M.D. ’48, HON. ’04, B.A. ’46, A.A. ’44
Radiation Oncology; Affiliated Faculty, Department of
Radiation Oncology, Drexel University College of Medicine;
GW Emeritus Trustee
Carlos R. Diaz, M.D. ’72, RESD ’75
President and Owner, Aeromedical Services
Daniel Ein, M.D., FACP, FAAAAI, FACAAI
Allergy, Asthma, and Immunology; Clinical Professor of
Medicine, GW School of Medicine and Health Sciences; Director,
Allergy & Sinus Center, GW Medical Faculty Associates
Thomas E. Flynn, M.D. ’86
Ophthalmology, Ellsworth Uveitis & Retina Care
Jeanne G. Holzgrefe, M.D. ’96, Ph.D., M.P.H.
Psychiatry; Chevy Chase Psychiatric Services; Assistant
Clinical Professor of Psychiatry and Behavioral Sciences, GW
School of Medicine and Health Sciences
Floyd Alexander Katske, M.D. ’76, RESD ’77
Urology; Clinical Assistant Professor of Urology, David Geffen
School of Medicine, UCLA
Jay E. Katzen, M.D. ’72, B.A. ’67
Ophthalmology; The Eye Center; GW Board of Trustees
Kerry L. Kuhn, M.D. ’73, RESD ’77, B.A. ’70, FACOG
OB/GYN; Private Practice; Senior Vice President of VitalMD
Gerald S. Lazarus, M.D. ’63
Dermatology; Professor of Dermatology, Johns Hopkins
University; Former Member, GW Board of Trustees
John C. Pan, M.D. ’70, RESD ’74
OB/GYN; Founder, Center for Integrative Medicine, GW
School of Medicine and Health Sciences
Smita H. Patel, M.D., DFAPA
Psychiatry, Assistant Clinical Professor of Psychiatry and
Behavioral Science, GW School of Medicine and Health Sciences
Richard G. Popiel, M.D. ’81, RESD ’83, M.B.A., B.S. ’75
Internal Medicine; Executive Vice President, Healthcare
Services, Chief Medical Officer, Cambia Health Solutions &
Regence Health Insurance Company
Rakesh C. Sahni, M.D.
Cardiology; Maryland Cardiology Associates

Dennis Narango, M.A., CFRE
Associate Dean, SMHS, and Associate Vice President for
GW Medicine Development and Alumni Relations
P.S. If you are 70 ½ or older, you can take advantage of a simple way to benefit
the GW School of Medicine and Health Sciences and receive tax benefits
in return. You can give up to $100,000 annually from your IRA directly to
SMHS without having to pay income taxes on the money. These gifts count
toward your IRA’s minimum distribution requirements and benefit you
regardless of whether you itemize deductions on your income tax returns.
Visit gwu.planmylegacy.org/ira-charitable-rollover for more information.

Mark W. Surrey, M.D. ’72, FACOG, FACS
OB/GYN-Reproductive Endocrinology; Professor & Clinical
Director, Reproductive Surgery, UCLA; Co-Founder and
Medical Director, Southern California Reproductive Center
Allan B. Weingold, M.D., HON. ’98
OB/GYN; Professor Emeritus, Former Chair of OB/GYN,
Former Vice President for Medical Affairs and Executive Dean,
The George Washington University
Art B. Wong, M.D. ’67
Emergency Medicine; Founder, Emergency Physicians
Medical Group, PC
The SMHS Board of Advisors offers the dean of the School of Medicine and Health
Sciences recommendations on strategic priorities and important issues for the school, and
provides generous support and advocacy.
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THE POWER AND PROMISE OF MEDICINE
Marcus Mitchell, a fourth-year medical student at SMHS and recipient of the Power and Promise scholarship,
found himself relieved with the reduction of his student loan debt and inspired to give back. “I want to have my
own scholarship fund,” he says, “and help some [unsuspecting] student who’s doing a good job.”
Read more on page 29.

